ENTITY
Biogen Inc

Biogen Inc (BIIB US)

144
Analysis
Health CareUnited States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
more
bearishS&P 500 INDEX
09 Jan 2019 03:12

U.S. Equity Strategy: Oversold Rally Continues

A combination of, optimism surrounding U.S.-China trade talks, and Fed Chairman Powell’s comments have led to a continuation of the oversold bounce...

Logo
580 Views
Share
29 Oct 2018 13:52

Smartkarma’s Week That Was in JP/​​​​KR: Market Turbulence 10 Years After 2008, Coway, & Celltrion

The Korean and Japanese stock markets have fallen sharply in October. Nikkei is down 12% and KOSPI is down 14% in October. It has been 10 years...

Logo
318 Views
Share
22 Oct 2018 22:52

Samsung BioLogics Update

Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...

Share
bullishEisai Co Ltd
03 Jul 2018 20:11

Merck Alliance Provides Stability to Deal With the Outcome of High Risk Alzheimer’s R&D in FY19

We upgrade Eisai Co Ltd (4523 JP) to “Equal-weight” after reviewing our model post FY17 (YE Mar-18) earnings, in light of the augmented peak sales...

x